Business Wire

FOURKITES

23.9.2022 09:01:38 CEST | Business Wire | Press release

Share
FourKites’ Latest European Premier Carrier List Reflects ROI of High-quality Real-Time Supply Chain Visibility Data

Leading real-time supply chain visibility provider FourKites today published its global Premier Carrier List (PCL), which recognises the rapidly growing community of brokers, carriers and 3PLs who are achieving the highest standards of visibility-related operational excellence across all modes of transport.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220923005062/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

FourKites’ Latest European Premier Carrier List Reflects ROI of High-quality Real-Time Supply Chain Visibility Data (Graphic: Business Wire)

To qualify for the PCL, carriers must demonstrate an ability to provide high-quality, consistent and accurate data on the vast majority of their shipments, thereby enabling their shipper customers and other ecosystem partners to streamline operations, increase the speed of shipping dock turn times, reduce inventory levels and optimise labour costs.

In the first half of 2022, 685 carriers were named to the PCL, which included an 8% increase for carriers based in Europe. These Premier Carriers demonstrated a significantly higher tracking percentage, on average, versus non-PCL carriers. Over the last six months, carriers who qualified for the Premier Carrier List tracked an average of 92.6% of their over-the-road shipments with real-time visibility, while non-PCL carriers tracked only 74.3% of their shipments.

“We partnered with FourKites because we wanted to grow our business,” says Vladas Stončius, CCO, Vlantana. “Increasingly, suppliers expect carriers to provide real-time data on all shipments. Thanks to FourKites, we’re able to do that efficiently and consistently, which has enabled us to win bigger customers and boost our margins.”

Notably, Premier Carriers witnessed higher growth rates than their non-PCL counterparts. In Europe, from H2 2021 to H1 2022, Premier Carriers experienced shipment volume growth of 9%, compared to non-PCL carriers in the region, who saw shipment volume contract 2%.

“Qualifying for FourKites’ Premier Carrier List is an increasingly important distinction for carriers, brokers and 3PLs who need to stand out in an increasingly competitive and volatile market,” said Jason Eversole, Vice President, Carrier Operations & Strategy, FourKites. “We’re pleased to see continued growth in the total number of Premier Carriers, and equally pleased to see the clear business benefits they are experiencing as a result of their visibility-related excellence.”

The Premier Carrier List is available here, where users can access and search the list according to carrier capabilities, transportation modes, geographies serviced and other relevant criteria.

Premier Carriers speak to program benefits:

"Transervice is honored to be recognised as a FourKites Premier Carrier. FourKites has enabled Transervice, and our clients, with unparalleled visibility into our logistics operations. This capability ensures complete transparency throughout the supply chain and promotes efficient resource utilisation. We are proud to partner with FourKites, and we look forward to their continued growth and innovation."

- Tom Poduch, Senior Director, Solutions, at Transervice

Van den Bosch is always on the lookout for new opportunities to make its supply chain more efficient and sustainable. Fueled by data, insights and knowledge, innovation and digitalisation are key drivers. The qualification for Premier Carrier is a nice recognition and confirmation of our position as the supply changer in bulk.”

- Marrit Hopmans, Data & Applications Manager, Van den Bosch

“As a former employee of FourKites, I’ve experienced firsthand how imperative their technology is to the entire industry. TransLoop is extremely proud to be recognised as a FourKites Premier Carrier. We will continue to do whatever our shipper and carrier partners need us to do for TransLoop to be the most transparent and reliable broker partner in the industry.”

- Nick Reasoner, CEO, TransLoop

About FourKites

Leading global supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.8 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching more than 200 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,100 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit www.fourkites.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220923005062/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 08:49:00 CEST | Press release

STC-1010 is a first-in-class allogeneic in vivo immunotherapy for which the FDA has authorized clinical evaluation in the U.S. under the BreAK-CRC001 study. This strategic milestone enables the company to execute a global clinical strategy following European regulatory approvals (ANSM, AFMPS), first patients dosed with preliminary results and good tolerability observed in early Phase Ia. First data are expected to be presented during ESMO annual congress 2026. Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FD

Tide Crosses 2 Million Members Worldwide - Big Step Forward in Mission to Support and Grow Small Businesses27.5.2026 08:00:00 CEST | Press release

Continuing to grow in the UK and internationally, with India seeing especially strong member growth in the last 12 months In the UK, Tide has 15% market share and has helped small businesses access over £1.75bn in credit Rapid roll out of products; from admin, accounting and tax tools; subscription options; payment solutions; government registrations; bill payments and credit Tide, the UK’s leading business management platform, today announces it has crossed 2 million members globally, with India in particular seeing strong growth. More than 1.1 million small businesses joined Tide in India since the company launched there in December 2022. This makes India Tide’s fastest-growing market by member acquisition. The UK is Tide’s home market, with 900,000 SMEs, 15% market share, and the majority of the company’s revenue. Tide’s steadily expanding its presence in Europe, with Germany and France, where the platform is gaining strong traction, thanks to millions of small businesses turning to

Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 202627.5.2026 08:00:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific and investor media only.In the OLINGUITO Phase 3 study in radiographic (r) and non-radiographic (nr) axial spondyloarthritis (axSpA) a significantly greater proportion of patients achieved the prespecified primary endpoint of ASAS40 with filgotinib compared with placebo at week 16.The improvements in signs and symptoms of axSpA with filgotinib, an oral, once-daily JAK1 preferential inhibitor, were observed as early as week 1 and maintained over 52 weeks of treatment.In the r-axSpA and nr-axSpA filgotinib groups, of those achieving a response in the prespecified primary endpoint of ASAS40 at week 16, 84.6% and 78.0% maintained their responses to week 52, respectively.In OLINGUITO no new safety signals were observedfor filgotinib over 52 weeks, and the safety profile was consistent with the known overall safety profile.Primary results from the Phase 3 OLINGUITO tria

Royal London Asset Management Expands Relationship with SS&C to Service New Australian Funds27.5.2026 00:00:00 CEST | Press release

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Royal London Asset Management, a leading U.K. fund management company, has extended its relationship with SS&C. SS&C Global Investor & Distribution Solutions will provide fund administration and unit registry services for its new range of Australian active funds, including: Royal London Global Equity Diversified Fund Royal London Global Equity Enhanced Fund Royal London Global Equity Select Fund Royal London Short Duration Global High Yield Bond Fund RLAM is part of Royal London, the U.K.’s largest mutual life, pensions and investment company. SS&C services approximately £72bn in assets under management across its U.K. fund range. Equity Trustees will serve as the Responsible Entity for RLAM’s new funds, which have launched with around AUD $1 billion in AUM. The unit trusts are structured as feeder funds, providing investors with indirect exposure to RLAM’s range of Dublin-domiciled Undertakings for Collective Investm

SLB Announces Date for Second-Quarter 2026 Results Conference Call26.5.2026 19:00:00 CEST | Press release

SLB (NYSE: SLB) will hold a conference call on July 24, 2026, to discuss the results for the second quarter ending June 30, 2026. The conference call is scheduled to begin at 9:30 a.m. U.S. Eastern time and a press release regarding the results will be issued at 7:00 a.m. U.S. Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 715-9871 within North America or +1 (646) 307-1963 outside of North America approximately 10 minutes prior to the start of the call and the access code is 3440360. A webcast of the conference call will be broadcast simultaneously at https://events.q4inc.com/attendee/157027565 on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until July 31, 2026, and can be accessed by dialing +1 (800) 770-2030 within North America or +1

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye